PhD, 2009, Univ. of California, Berkley
We are interested in dissecting the distinct functions of synaptic cell-adhesion molecules implicated in neuropsychiatric disorders and addiction in the context of disease-relevant brain circuits. Using cutting-edge multidisciplinary techniques, we are able to interrogate these molecules with cell-type and synapse-specific resolution.
PhD, 2009, Columbia University
Molecular Mechanisms of ion channel function. Examining structural and regulatory mechanisms of the Acid-sensing ion channels using electrophysiology, fluorescence, spectroscopy, and structural biology.
Bayer, K. Ulrich
PhD, 1996, Heinrich-Pette-Institute
Molecular mechanisms of synaptic plasticity. Strategies for restoring normal synaptic plasticity in neurological disorders.
Benke, Timothy A.
MD/PhD, 1995, Baylor College of Medicine
Mechanisms of synaptic plasticity and impacts of development and epilepsy.
PhD, University of Bordeaux Segalen, France
The control of cerebral blood flow by ion channels and calcium signaling in the pericytes, endothelial cells, and smooth muscle cells that constitute the brain microcirculation. We use this information to combat brain diseases with a vascular component.
Dell'Acqua, Mark L.
Professor and Vice Chairman
PhD, 1995, Harvard Univ.
Organization of signaling complexes by protein kinase and phosphatase anchoring proteins; mechanisms regulating neuronal second messenger signaling in synaptic plasticity.
PhD, 2003, Univ. of Alberta
We study the synaptic mechanisms by which neuromodulators like dopamine and acetylcholine are encoded in mesolimbic and nigrostriatal circuits through their G-protein coupled receptors and the alterations that occur in these systems in neurological and psychiatric diseases.
Freed, Curt R.
MD, 1969, Harvard Univ.
The dynamic role of dopamine in movement; neural transplantation for Parkinson’s disease.
PhD, 2018, Medical University of South Carolina
We are interested in the basal ganglia circuits that regulate motivation, mood and reward with a particular focus on addition using a combination of behavioral neuroscience, optogenetics, chemogenetics, calcium/neurotransmitter imaging and electrophysiology.
Hoffman, Paula L.
PhD, 1974, City Univ. of New York
Neuropharmacology; mechanisms of alcohol tolerance, dependence, and craving; genetic aspects of alcohol dependence and affective disorders; biochemical/molecular biological/genetic analysis of CNS receptors and signal transduction systems.
Kennedy, Matthew J.
PhD, 2003, Univ. of Washington
Molecular mechanisms of activity-triggered synaptic remodeling.
Kutateladze, Tatiana G.
PhD, 1988, Moscow State Univ.
Epigenetics, phosphoinositide signaling, structural biology, NMR and crystal structures of proteins implicated in cancer, structure based drug design.
Sather, William A.
PhD, 1988, Univ. of Washington
Signaling through calcium channels in neurons.
Serkova, Natalie J.
PhD, 1996, Univ. of Bremen
Animal Imaging (MRI, PET, CT); Magnetic Resonance Spectroscopy (MRS) based metabonomics; Cancer Metabolism and Physiology; Anti-Cancer Drugs; Ischemia/Reperfusion in Organs.
Sikela, James M.
PhD, 1983, Case Western Reserve Univ.
Neurogenomics; disease gene discovery; human genome evolution and variation.